These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 18056156)

  • 1. Enzyme replacement therapy in a murine model of Morquio A syndrome.
    Tomatsu S; Montaño AM; Ohashi A; Gutierrez MA; Oikawa H; Oguma T; Dung VC; Nishioka T; Orii T; Sly WS
    Hum Mol Genet; 2008 Mar; 17(6):815-24. PubMed ID: 18056156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase.
    Tomatsu S; Montaño AM; Gutierrez M; Grubb JH; Oikawa H; Dung VC; Ohashi A; Nishioka T; Yamada M; Yamada M; Tosaka Y; Trandafirescu GG; Orii T
    Mol Genet Metab; 2007 May; 91(1):69-78. PubMed ID: 17336563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of MPS IVA mouse (Galnstm(hC79S.mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase.
    Tomatsu S; Gutierrez M; Nishioka T; Yamada M; Yamada M; Tosaka Y; Grubb JH; Montaño AM; Vieira MB; Trandafirescu GG; Peña OM; Yamaguchi S; Orii KO; Orii T; Noguchi A; Laybauer L
    Hum Mol Genet; 2005 Nov; 14(22):3321-35. PubMed ID: 16219627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease.
    Tomatsu S; Orii KO; Vogler C; Nakayama J; Levy B; Grubb JH; Gutierrez MA; Shim S; Yamaguchi S; Nishioka T; Montano AM; Noguchi A; Orii T; Kondo N; Sly WS
    Hum Mol Genet; 2003 Dec; 12(24):3349-58. PubMed ID: 14583446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine model (Galns(tm(C76S)slu)) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins.
    Tomatsu S; Vogler C; Montaño AM; Gutierrez M; Oikawa H; Dung VC; Orii T; Noguchi A; Sly WS
    Mol Genet Metab; 2007 Jul; 91(3):251-8. PubMed ID: 17498992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions?
    Tomatsu S; Montaño AM; Oikawa H; Dung VC; Hashimoto A; Oguma T; Gutiérrez ML; Takahashi T; Shimada T; Orii T; Sly WS
    Mol Genet Metab; 2015 Feb; 114(2):195-202. PubMed ID: 24953405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated virus gene transfer in Morquio A disease - effect of promoters and sulfatase-modifying factor 1.
    Alméciga-Díaz CJ; Montaño AM; Tomatsu S; Barrera LA
    FEBS J; 2010 Sep; 277(17):3608-19. PubMed ID: 20716181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice.
    Dvorak-Ewell M; Wendt D; Hague C; Christianson T; Koppaka V; Crippen D; Kakkis E; Vellard M
    PLoS One; 2010 Aug; 5(8):e12194. PubMed ID: 20808938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome.
    Tomatsu S; Montaño AM; Dung VC; Ohashi A; Oikawa H; Oguma T; Orii T; Barrera L; Sly WS
    Mol Ther; 2010 Jun; 18(6):1094-102. PubMed ID: 20332769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A).
    Tomatsu S; Montaño AM; Nishioka T; Gutierrez MA; Peña OM; Tranda Firescu GG; Lopez P; Yamaguchi S; Noguchi A; Orii T
    Hum Mutat; 2005 Dec; 26(6):500-12. PubMed ID: 16287098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucopolysaccharidosis IVA (Morquio A syndrome): clinical, biological and therapeutic aspects].
    Bouzidi H; Khedhiri S; Laradi S; Ferchichi S; Daudon M; Miled A
    Ann Biol Clin (Paris); 2007; 65(1):5-11. PubMed ID: 17264033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome).
    Lyseng-Williamson KA
    BioDrugs; 2014 Oct; 28(5):465-75. PubMed ID: 25200032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of Turkish mucopolysaccharidosis IVA (Morquio A) patients: identification of novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene.
    Terzioglu M; Tokatli A; Coskun T; Emre S
    Hum Mutat; 2002 Dec; 20(6):477-8. PubMed ID: 12442278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylgalactosamine-6-sulfatase protein detection in MPS IVA patient and unaffected control samples.
    Parkinson-Lawrence EJ; Muller VJ; Hopwood JJ; Brooks DA
    Clin Chim Acta; 2007 Feb; 377(1-2):88-91. PubMed ID: 17027703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucopolysaccharidosis type IV: N-acetylgalactosamine-6-sulfatase mutations in Tunisian patients.
    Laradi S; Tukel T; Khediri S; Shabbeer J; Erazo M; Chkioua L; Chaabouni M; Ferchichi S; Miled A; Desnick RJ
    Mol Genet Metab; 2006 Mar; 87(3):213-8. PubMed ID: 16378744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucopolysaccharidosis IVA (Morquio A): identification of novel common mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene in Italian patients.
    Tomatsu S; Filocamo M; Orii KO; Sly WS; Gutierrez MA; Nishioka T; Serrato OP; Di Natale P; Montaño AM; Yamaguchi S; Kondo N; Orii T; Noguchi A
    Hum Mutat; 2004 Aug; 24(2):187-8. PubMed ID: 15241807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elosulfase alfa (BMN 110) for the treatment of mucopolysaccharidosis IVA (Morquio A Syndrome).
    Hendriksz CJ
    Expert Rev Clin Pharmacol; 2016 Dec; 9(12):1521-1532. PubMed ID: 27855521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Substrate Degradation Enzyme Therapy for Mucopolysaccharidosis IVA Murine Model.
    Sawamoto K; Tomatsu S
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.
    Tomatsu S; Sawamoto K; Alméciga-Díaz CJ; Shimada T; Bober MB; Chinen Y; Yabe H; Montaño AM; Giugliani R; Kubaski F; Yasuda E; Rodríguez-López A; Espejo-Mojica AJ; Sánchez OF; Mason RW; Barrera LA; Mackenzie WG; Orii T
    Drug Des Devel Ther; 2015; 9():1937-53. PubMed ID: 25897204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elosulfase alfa.
    Haddley K
    Drugs Today (Barc); 2014 Jul; 50(7):475-83. PubMed ID: 25101330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.